EP0547166A4 - - Google Patents

Info

Publication number
EP0547166A4
EP0547166A4 EP19910918302 EP91918302A EP0547166A4 EP 0547166 A4 EP0547166 A4 EP 0547166A4 EP 19910918302 EP19910918302 EP 19910918302 EP 91918302 A EP91918302 A EP 91918302A EP 0547166 A4 EP0547166 A4 EP 0547166A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19910918302
Other versions
EP0547166A1 (en
Inventor
Judy Lieberman
Malcolm Gefter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immulogic Pharmaceutical Corp
Tufts Medical Center Inc
Original Assignee
Immulogic Pharmaceutical Corp
New England Medical Center Hospitals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharmaceutical Corp, New England Medical Center Hospitals Inc filed Critical Immulogic Pharmaceutical Corp
Publication of EP0547166A1 publication Critical patent/EP0547166A1/en
Publication of EP0547166A4 publication Critical patent/EP0547166A4/xx
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP91918302A 1990-09-06 1991-09-06 Pathogen-specific ctl therapy Ceased EP0547166A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57882890A 1990-09-06 1990-09-06
US578828 1990-09-06
CA002089488A CA2089488A1 (en) 1990-09-06 1991-09-06 Pathogen-specific ctl therapy

Publications (2)

Publication Number Publication Date
EP0547166A1 EP0547166A1 (en) 1993-06-23
EP0547166A4 true EP0547166A4 (OSRAM) 1994-03-09

Family

ID=25675897

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91918302A Ceased EP0547166A1 (en) 1990-09-06 1991-09-06 Pathogen-specific ctl therapy

Country Status (4)

Country Link
EP (1) EP0547166A1 (OSRAM)
AU (1) AU660422B2 (OSRAM)
CA (1) CA2089488A1 (OSRAM)
WO (1) WO1992004462A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
EP0594638A1 (en) * 1991-06-03 1994-05-04 Syntello Vaccine Development Ab Peptides for use in induction of t cell activation against hiv-1
DK0771322T3 (da) 1993-11-23 2008-11-24 Univ California Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
CA2230195A1 (en) * 1995-08-21 1997-02-27 Duke University A method to increase the density of antigen on antigen presenting cells
US5994308A (en) 1996-02-28 1999-11-30 Board Of Trustees Of Southern Illinois University Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
DE19710496A1 (de) * 1997-03-13 1998-09-17 Boehringer Mannheim Gmbh Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260714A2 (en) * 1986-09-19 1988-03-23 Oncogen Limited Partnership The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260714A2 (en) * 1986-09-19 1988-03-23 Oncogen Limited Partnership The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9204462A1 *

Also Published As

Publication number Publication date
WO1992004462A1 (en) 1992-03-19
AU660422B2 (en) 1995-06-29
AU8737991A (en) 1992-03-30
CA2089488A1 (en) 1993-03-07
EP0547166A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
EP0460437A3 (OSRAM)
DE4190020T (OSRAM)
EP0453641A3 (OSRAM)
US5030853B1 (OSRAM)
FR2664537B1 (OSRAM)
DE4190445T (OSRAM)
DE4092603T (OSRAM)
FR2670510B1 (OSRAM)
FR2670572B1 (OSRAM)
DE4190249T (OSRAM)
IN171736B (OSRAM)
JPH0490378U (OSRAM)
DE4190022T (OSRAM)
IN171188B (OSRAM)
ECSM90482U (OSRAM)
IN171756B (OSRAM)
JPH0493205U (OSRAM)
JPH0491345U (OSRAM)
ECSM90486U (OSRAM)
ECSM90488U (OSRAM)
JPH0489286U (OSRAM)
ECSM90504U (OSRAM)
JPH047750U (OSRAM)
AU6013290A (OSRAM)
IL96174A0 (OSRAM)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930311

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19940114

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19960219

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19980307